NuVasive, Inc. (NUVA)
Upgrades & Downgrades
Latest NUVA news
Radcliffe Capital Management, L.P. Acquires Stake in Portage Fintech Acquisition Corp
27 July 2023
Radcliffe Capital Management, L.P. (Trades, Portfolio), a prominent investment firm, recently made a significant acquisition in the stock market.
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall
11 May 2023
NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript
10 May 2023
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Chris Barry - Chief Executive Officer...
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
10 May 2023
NuVasive (NUVA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.54 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff
4 May 2023
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
Is NuVasive (NUVA) a Great Value Stock Right Now?
1 May 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
New Strong Buy Stocks for April 26th
26 April 2023
EGY, MSGS, NUVA, NWG and VCISY have been added to the Zacks Rank #1 (Strong Buy) List on April 26, 2022.
NUVA vs. ABT: Which Stock Is the Better Value Option?
25 April 2023
Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two stocks is more attractive to value investors?
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?
24 March 2023
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?